CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112622630
- Phone
- 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-Q Report Quarterly Report
- 10-K405/A Other 10-K405/A
- 10-K405 Other 10-K405
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- 10-C Other 10-C
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- SC 13D/A Stake Beneficial Ownership Report
- 10-Q Report Quarterly Report
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Item 5 · Item 7
- 10-Q Report Quarterly Report
- 10-K405 Other 10-K405
- 10-Q Report Quarterly Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- 424B3 Offering Prospectus
- SC 13D/A Stake Beneficial Ownership Report
Page 49 of 50 · 983 filings